Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Nicolás Pérez-MauadInstituto de Química y Metabolismo del Fármaco (IQUIMEFA), CONICET-Universidad de Buenos Aires, Buenos Aires C1113, Argentina.ORCID 0009-0009-7348-7976
Lucas N AlbercaLaboratorio de Investigación y Desarrollo de Bioactivos (LIDeB), Departamento de Ciencias Biológicas, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, La Plata C1904, Argentina.
Alejandra C SchoijetSignaling and Adaptive Mechanisms in Trypanosomatids Laboratory, Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres", Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires C1428, Argentina.
Salome C Vilchez LarreaSignaling and Adaptive Mechanisms in Trypanosomatids Laboratory, Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres", Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires C1428, Argentina.ORCID 0000-0001-8302-1509
Emilia M BarrionuevoLaboratorio de Investigación y Desarrollo de Bioactivos (LIDeB), Departamento de Ciencias Biológicas, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, La Plata C1904, Argentina.ORCID 0000-0003-3271-6305
Giuliana MuracaLaboratorio de Investigación y Desarrollo de Bioactivos (LIDeB), Departamento de Ciencias Biológicas, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, La Plata C1904, Argentina.ORCID 0000-0002-4785-8050
Valeria SülsenInstituto de Química y Metabolismo del Fármaco (IQUIMEFA), CONICET-Universidad de Buenos Aires, Buenos Aires C1113, Argentina.ORCID 0000-0002-9322-5748
Catalina D Alba-SotoInstituto de Investigaciones en Microbiología y Parasitología Médica (IMPaM), CONICET-Universidad de Buenos Aires, Buenos Aires C1121, Argentina.ORCID 0000-0002-2724-0421
Guillermo D AlonsoSignaling and Adaptive Mechanisms in Trypanosomatids Laboratory, Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres", Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires C1428, Argentina.ORCID 0000-0001-9386-9431
Alan TaleviLaboratorio de Investigación y Desarrollo de Bioactivos (LIDeB), Departamento de Ciencias Biológicas, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, La Plata C1904, Argentina.ORCID 0000-0003-3178-826X
Funding
Agencia I+D+i 2021-0404Agencia I+D+i 2021-0478Consejo Nacional de Investigaciones Científicas y Técnicas 2021-2023-03073Joint Canada- Israel Health Research Program 109929
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Application of Data-Centric Supervised Machine Learning to Predict Phenotypic Activity Against Clinically Relevant Stages of · full record | OpenQuestion